APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Piroxicam Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Piroxicam Capsules Industry Growth and Trends Forecast to 2032

Report ID 174026060127 December 2025101 pages

Choose your research edition.

Industry ResearchPiroxicam Capsules Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Piroxicam Capsules Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Piroxicam Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Piroxicam Capsules Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Piroxicam Capsules Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Piroxicam Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Piroxicam Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Piroxicam Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Piroxicam Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Piroxicam Capsules include Chongqing Kerui Pharmaceutical, Pfizer, Guangzhou Ouhua Pharmaceutica, Baiyunshan, Guangdong Zhongsheng Pharmaceutical, Guangdong Xinfeng Pharmaceutical, Guangdong Pidi Pharmaceutical, Teva Pharmaceuticals USA and SK Chemical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Piroxicam Capsules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Piroxicam Capsules market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Piroxicam Capsules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Piroxicam Capsules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Piroxicam Capsules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Piroxicam Capsules Market by Company

Chongqing Kerui Pharmaceutical

Pfizer

Guangzhou Ouhua Pharmaceutica

Baiyunshan

Guangdong Zhongsheng Pharmaceutical

Guangdong Xinfeng Pharmaceutical

Guangdong Pidi Pharmaceutical

Teva Pharmaceuticals USA

SK Chemical

Nouvasant Group

Elikem Pharmaceuticals

DevLife

AdvaCare Pharma

Piroxicam Capsules Segment by Type

Regular Release

Modified Release

Piroxicam Capsules Segment by Application

Hospital

Clinic

Pharmacy

Piroxicam Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Piroxicam Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Piroxicam Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Piroxicam Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Piroxicam Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Piroxicam Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Regular Release Table 2. Major Company of Modified Release Table 3. Global Piroxicam Capsules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Piroxicam Capsules Sales by Type (2021-2026) & (K Units) Table 5. Global Piroxicam Capsules Sales Market Share in Volume by Type (2021-2026) Table 6. Global Piroxicam Capsules Sales by Type (2021-2026) & (US$ Million) Table 7. Global Piroxicam Capsules Sales Market Share in Value by Type (2021-2026) Table 8. Global Piroxicam Capsules Price by Type (2021-2026) & (US$/Unit) Table 9. Global Piroxicam Capsules Sales by Type (2027-2032) & (K Units) Table 10. Global Piroxicam Capsules Sales Market Share in Volume by Type (2027-2032) Table 11. Global Piroxicam Capsules Sales by Type (2027-2032) & (US$ Million) Table 12. Global Piroxicam Capsules Sales Market Share in Value by Type (2027-2032) Table 13. Global Piroxicam Capsules Price by Type (2027-2032) & (US$/Unit) Table 14. North America Piroxicam Capsules Sales by Type (2021-2026) & (K Units) Table 15. North America Piroxicam Capsules Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Piroxicam Capsules Sales by Type (2021-2026) & (K Units) Table 17. Europe Piroxicam Capsules Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Piroxicam Capsules Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Piroxicam Capsules Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Piroxicam Capsules Sales by Type (2021-2026) & (K Units) Table 21. Latin America Piroxicam Capsules Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Piroxicam Capsules Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Piroxicam Capsules Sales by Type (2021-2026) & (US$ Million) Table 24. Piroxicam Capsules Industry Trends Table 25. Piroxicam Capsules Industry Drivers Table 26. Piroxicam Capsules Industry Opportunities and Challenges Table 27. Piroxicam Capsules Industry Restraints Table 28. Global Piroxicam Capsules Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Piroxicam Capsules Revenue Market Share by Company (2021-2026) Table 30. Global Piroxicam Capsules Sales by Company (2021-2026) & (K Units) Table 31. Global Piroxicam Capsules Sales Share by Company (2021-2026) Table 32. Global Piroxicam Capsules Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Piroxicam Capsules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Piroxicam Capsules Major Company Production Sites and Headquarters Table 35. Global Piroxicam Capsules Company, Product Type & Application Table 36. Global Piroxicam Capsules Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Piroxicam Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Piroxicam Capsules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Piroxicam Capsules Sales by Region (2021-2026) & (K Units) Table 41. Global Piroxicam Capsules Sales Market Share in Volume by Region (2021-2026) Table 42. Global Piroxicam Capsules Sales by Region (2021-2026) & (US$ Million) Table 43. Global Piroxicam Capsules Sales Market Share in Value by Region (2021-2026) Table 44. Global Piroxicam Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Piroxicam Capsules Sales by Region (2027-2032) & (K Units) Table 46. Global Piroxicam Capsules Sales Market Share in Volume by Region (2027-2032) Table 47. Global Piroxicam Capsules Sales by Region (2027-2032) & (US$ Million) Table 48. Global Piroxicam Capsules Sales Market Share in Value by Region (2027-2032) Table 49. Global Piroxicam Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Piroxicam Capsules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Piroxicam Capsules Sales by Application (2021-2026) & (K Units) Table 52. Global Piroxicam Capsules Sales Market Share in Volume by Application (2021-2026) Table 53. Global Piroxicam Capsules Sales by Application (2021-2026) & (US$ Million) Table 54. Global Piroxicam Capsules Sales Market Share in Value by Application (2021-2026) Table 55. Global Piroxicam Capsules Price by Application (2021-2026) & (US$/Unit) Table 56. Global Piroxicam Capsules Sales by Application (2027-2032) & (K Units) Table 57. Global Piroxicam Capsules Sales Market Share in Volume by Application (2027-2032) Table 58. Global Piroxicam Capsules Sales by Application (2027-2032) & (US$ Million) Table 59. Global Piroxicam Capsules Sales Market Share in Value by Application (2027-2032) Table 60. Global Piroxicam Capsules Price by Application (2027-2032) & (US$/Unit) Table 61. North America Piroxicam Capsules Sales by Application (2021-2026) & (K Units) Table 62. North America Piroxicam Capsules Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Piroxicam Capsules Sales by Application (2021-2026) & (K Units) Table 64. Europe Piroxicam Capsules Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Piroxicam Capsules Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Piroxicam Capsules Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Piroxicam Capsules Sales by Application (2021-2026) & (K Units) Table 68. Latin America Piroxicam Capsules Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Piroxicam Capsules Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Piroxicam Capsules Sales by Application (2021-2026) & (US$ Million) Table 71. Chongqing Kerui Pharmaceutical Company Information Table 72. Chongqing Kerui Pharmaceutical Business Overview Table 73. Chongqing Kerui Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Chongqing Kerui Pharmaceutical Piroxicam Capsules Product Portfolio Table 75. Chongqing Kerui Pharmaceutical Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Pfizer Piroxicam Capsules Product Portfolio Table 80. Pfizer Recent Development Table 81. Guangzhou Ouhua Pharmaceutica Company Information Table 82. Guangzhou Ouhua Pharmaceutica Business Overview Table 83. Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Product Portfolio Table 85. Guangzhou Ouhua Pharmaceutica Recent Development Table 86. Baiyunshan Company Information Table 87. Baiyunshan Business Overview Table 88. Baiyunshan Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Baiyunshan Piroxicam Capsules Product Portfolio Table 90. Baiyunshan Recent Development Table 91. Guangdong Zhongsheng Pharmaceutical Company Information Table 92. Guangdong Zhongsheng Pharmaceutical Business Overview Table 93. Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Product Portfolio Table 95. Guangdong Zhongsheng Pharmaceutical Recent Development Table 96. Guangdong Xinfeng Pharmaceutical Company Information Table 97. Guangdong Xinfeng Pharmaceutical Business Overview Table 98. Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Product Portfolio Table 100. Guangdong Xinfeng Pharmaceutical Recent Development Table 101. Guangdong Pidi Pharmaceutical Company Information Table 102. Guangdong Pidi Pharmaceutical Business Overview Table 103. Guangdong Pidi Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Guangdong Pidi Pharmaceutical Piroxicam Capsules Product Portfolio Table 105. Guangdong Pidi Pharmaceutical Recent Development Table 106. Teva Pharmaceuticals USA Company Information Table 107. Teva Pharmaceuticals USA Business Overview Table 108. Teva Pharmaceuticals USA Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Teva Pharmaceuticals USA Piroxicam Capsules Product Portfolio Table 110. Teva Pharmaceuticals USA Recent Development Table 111. SK Chemical Company Information Table 112. SK Chemical Business Overview Table 113. SK Chemical Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. SK Chemical Piroxicam Capsules Product Portfolio Table 115. SK Chemical Recent Development Table 116. Nouvasant Group Company Information Table 117. Nouvasant Group Business Overview Table 118. Nouvasant Group Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Nouvasant Group Piroxicam Capsules Product Portfolio Table 120. Nouvasant Group Recent Development Table 121. Elikem Pharmaceuticals Company Information Table 122. Elikem Pharmaceuticals Business Overview Table 123. Elikem Pharmaceuticals Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Elikem Pharmaceuticals Piroxicam Capsules Product Portfolio Table 125. Elikem Pharmaceuticals Recent Development Table 126. DevLife Company Information Table 127. DevLife Business Overview Table 128. DevLife Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. DevLife Piroxicam Capsules Product Portfolio Table 130. DevLife Recent Development Table 131. AdvaCare Pharma Company Information Table 132. AdvaCare Pharma Business Overview Table 133. AdvaCare Pharma Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. AdvaCare Pharma Piroxicam Capsules Product Portfolio Table 135. AdvaCare Pharma Recent Development Table 136. North America Piroxicam Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. North America Piroxicam Capsules Sales by Country (2021-2026) & (K Units) Table 138. North America Piroxicam Capsules Sales Market Share by Country (2021-2026) Table 139. North America Piroxicam Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 140. North America Piroxicam Capsules Sales Market Share Forecast by Country (2027-2032) Table 141. North America Piroxicam Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Piroxicam Capsules Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Piroxicam Capsules Market Share by Country (2021-2026) Table 144. North America Piroxicam Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Piroxicam Capsules Market Share Forecast by Country (2027-2032) Table 146. Europe Piroxicam Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Europe Piroxicam Capsules Sales by Country (2021-2026) & (K Units) Table 148. Europe Piroxicam Capsules Sales Market Share by Country (2021-2026) Table 149. Europe Piroxicam Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 150. Europe Piroxicam Capsules Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Piroxicam Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Piroxicam Capsules Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Piroxicam Capsules Market Share by Country (2021-2026) Table 154. Europe Piroxicam Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Piroxicam Capsules Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Piroxicam Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Piroxicam Capsules Sales by Country (2021-2026) & (K Units) Table 158. Asia-Pacific Piroxicam Capsules Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Piroxicam Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 160. Asia-Pacific Piroxicam Capsules Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Piroxicam Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Piroxicam Capsules Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Piroxicam Capsules Market Share by Country (2021-2026) Table 164. Asia-Pacific Piroxicam Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Piroxicam Capsules Market Share Forecast by Country (2027-2032) Table 166. Latin America Piroxicam Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Latin America Piroxicam Capsules Sales by Country (2021-2026) & (K Units) Table 168. Latin America Piroxicam Capsules Sales Market Share by Country (2021-2026) Table 169. Latin America Piroxicam Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 170. Latin America Piroxicam Capsules Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Piroxicam Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Piroxicam Capsules Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Piroxicam Capsules Market Share by Country (2021-2026) Table 174. Latin America Piroxicam Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Piroxicam Capsules Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Piroxicam Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Piroxicam Capsules Sales by Country (2021-2026) & (K Units) Table 178. Middle East and Africa Piroxicam Capsules Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Piroxicam Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 180. Middle East and Africa Piroxicam Capsules Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Piroxicam Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Piroxicam Capsules Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Piroxicam Capsules Market Share by Country (2021-2026) Table 184. Middle East and Africa Piroxicam Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Piroxicam Capsules Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Piroxicam Capsules Distributors List Table 189. Piroxicam Capsules Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Piroxicam Capsules Image Figure 2. Global Piroxicam Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Piroxicam Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Piroxicam Capsules Sales (2021-2032) & (K Units) Figure 5. Regular Release Image Figure 6. Global Regular Release Sales YoY Growth (2021-2032) & (K Units) Figure 7. Modified Release Image Figure 8. Global Modified Release Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Piroxicam Capsules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Piroxicam Capsules Market Share by Type 2025 VS 2032 Figure 11. North America Piroxicam Capsules Sales Market Share in Volume by Type in 2025 Figure 12. North America Piroxicam Capsules Sales Market Share in Value by Type in 2025 Figure 13. Europe Piroxicam Capsules Sales Market Share in Volume by Type in 2025 Figure 14. Europe Piroxicam Capsules Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Piroxicam Capsules Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Piroxicam Capsules Sales Market Share in Value by Type in 2025 Figure 17. Latin America Piroxicam Capsules Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Piroxicam Capsules Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Piroxicam Capsules Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Piroxicam Capsules Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Piroxicam Capsules Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Pharmacy Image Figure 28. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Piroxicam Capsules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Piroxicam Capsules Market Share by Application 2025 VS 2032 Figure 31. North America Piroxicam Capsules Sales Market Share in Volume by Application in 2025 Figure 32. North America Piroxicam Capsules Sales Market Share in Value by Application in 2025 Figure 33. Europe Piroxicam Capsules Sales Market Share in Volume by Application in 2025 Figure 34. Europe Piroxicam Capsules Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Piroxicam Capsules Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Piroxicam Capsules Sales Market Share in Value by Application in 2025 Figure 37. Latin America Piroxicam Capsules Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Piroxicam Capsules Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Piroxicam Capsules Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Piroxicam Capsules Sales Market Share in Value by Application in 2025 Figure 41. North America Piroxicam Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Piroxicam Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Piroxicam Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Piroxicam Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Piroxicam Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Piroxicam Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Piroxicam Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Piroxicam Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Piroxicam Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Piroxicam Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Piroxicam Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Piroxicam Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Piroxicam Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Piroxicam Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Piroxicam Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Piroxicam Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Piroxicam Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Piroxicam Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Piroxicam Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Piroxicam Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Piroxicam Capsules Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Piroxicam Capsules Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Regular Release
  • Modified Release
Applications
  • Hospital
  • Clinic
  • Pharmacy
Companies covered
  • Chongqing Kerui Pharmaceutical
  • Pfizer
  • Guangzhou Ouhua Pharmaceutica
  • Baiyunshan
  • Guangdong Zhongsheng Pharmaceutical
  • Guangdong Xinfeng Pharmaceutical
  • Guangdong Pidi Pharmaceutical
  • Teva Pharmaceuticals USA
  • SK Chemical
  • Nouvasant Group
  • Elikem Pharmaceuticals
  • DevLife
  • AdvaCare Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Piroxicam Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Piroxicam Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Piroxicam Capsules Market by Type
  6. 1.3.1 Regular Release
  7. 1.3.2 Modified Release
  8. 1.4 Global Piroxicam Capsules Market Size by Type
  9. 1.4.1 Global Piroxicam Capsules Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Piroxicam Capsules Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Piroxicam Capsules Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Piroxicam Capsules Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Piroxicam Capsules Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Piroxicam Capsules Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Piroxicam Capsules Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Piroxicam Capsules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Piroxicam Capsules Industry Trends
  2. 2.2 Piroxicam Capsules Industry Drivers
  3. 2.3 Piroxicam Capsules Industry Opportunities and Challenges
  4. 2.4 Piroxicam Capsules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Piroxicam Capsules Revenue (2021-2026)
  2. 3.2 Global Top Players by Piroxicam Capsules Sales (2021-2026)
  3. 3.3 Global Top Players by Piroxicam Capsules Price (2021-2026)
  4. 3.4 Global Piroxicam Capsules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Piroxicam Capsules Major Company Production Sites & Headquarters
  6. 3.6 Global Piroxicam Capsules Company, Product Type & Application
  7. 3.7 Global Piroxicam Capsules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Piroxicam Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Piroxicam Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Piroxicam Capsules Tier 1, Tier 2, and Tier 3
4 Piroxicam Capsules Regional Status and Outlook
  1. 4.1 Global Piroxicam Capsules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Piroxicam Capsules Historic Market Size by Region
  3. 4.2.1 Global Piroxicam Capsules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Piroxicam Capsules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Piroxicam Capsules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Piroxicam Capsules Forecasted Market Size by Region
  7. 4.3.1 Global Piroxicam Capsules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Piroxicam Capsules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Piroxicam Capsules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Piroxicam Capsules by Application
  1. 5.1 Piroxicam Capsules Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Pharmacy
  5. 5.2 Global Piroxicam Capsules Market Size by Application
  6. 5.2.1 Global Piroxicam Capsules Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Piroxicam Capsules Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Piroxicam Capsules Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Piroxicam Capsules Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Piroxicam Capsules Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Piroxicam Capsules Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Piroxicam Capsules Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Piroxicam Capsules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chongqing Kerui Pharmaceutical
  2. 6.1.1 Chongqing Kerui Pharmaceutical Company Information
  3. 6.1.2 Chongqing Kerui Pharmaceutical Business Overview
  4. 6.1.3 Chongqing Kerui Pharmaceutical Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chongqing Kerui Pharmaceutical Piroxicam Capsules Product Portfolio
  6. 6.1.5 Chongqing Kerui Pharmaceutical Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Piroxicam Capsules Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Guangzhou Ouhua Pharmaceutica
  14. 6.3.1 Guangzhou Ouhua Pharmaceutica Company Information
  15. 6.3.2 Guangzhou Ouhua Pharmaceutica Business Overview
  16. 6.3.3 Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Product Portfolio
  18. 6.3.5 Guangzhou Ouhua Pharmaceutica Recent Developments
  19. 6.4 Baiyunshan
  20. 6.4.1 Baiyunshan Company Information
  21. 6.4.2 Baiyunshan Business Overview
  22. 6.4.3 Baiyunshan Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Baiyunshan Piroxicam Capsules Product Portfolio
  24. 6.4.5 Baiyunshan Recent Developments
  25. 6.5 Guangdong Zhongsheng Pharmaceutical
  26. 6.5.1 Guangdong Zhongsheng Pharmaceutical Company Information
  27. 6.5.2 Guangdong Zhongsheng Pharmaceutical Business Overview
  28. 6.5.3 Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Product Portfolio
  30. 6.5.5 Guangdong Zhongsheng Pharmaceutical Recent Developments
  31. 6.6 Guangdong Xinfeng Pharmaceutical
  32. 6.6.1 Guangdong Xinfeng Pharmaceutical Company Information
  33. 6.6.2 Guangdong Xinfeng Pharmaceutical Business Overview
  34. 6.6.3 Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Product Portfolio
  36. 6.6.5 Guangdong Xinfeng Pharmaceutical Recent Developments
  37. 6.7 Guangdong Pidi Pharmaceutical
  38. 6.7.1 Guangdong Pidi Pharmaceutical Company Information
  39. 6.7.2 Guangdong Pidi Pharmaceutical Business Overview
  40. 6.7.3 Guangdong Pidi Pharmaceutical Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Guangdong Pidi Pharmaceutical Piroxicam Capsules Product Portfolio
  42. 6.7.5 Guangdong Pidi Pharmaceutical Recent Developments
  43. 6.8 Teva Pharmaceuticals USA
  44. 6.8.1 Teva Pharmaceuticals USA Company Information
  45. 6.8.2 Teva Pharmaceuticals USA Business Overview
  46. 6.8.3 Teva Pharmaceuticals USA Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Teva Pharmaceuticals USA Piroxicam Capsules Product Portfolio
  48. 6.8.5 Teva Pharmaceuticals USA Recent Developments
  49. 6.9 SK Chemical
  50. 6.9.1 SK Chemical Company Information
  51. 6.9.2 SK Chemical Business Overview
  52. 6.9.3 SK Chemical Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 SK Chemical Piroxicam Capsules Product Portfolio
  54. 6.9.5 SK Chemical Recent Developments
  55. 6.10 Nouvasant Group
  56. 6.10.1 Nouvasant Group Company Information
  57. 6.10.2 Nouvasant Group Business Overview
  58. 6.10.3 Nouvasant Group Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Nouvasant Group Piroxicam Capsules Product Portfolio
  60. 6.10.5 Nouvasant Group Recent Developments
  61. 6.11 Elikem Pharmaceuticals
  62. 6.11.1 Elikem Pharmaceuticals Company Information
  63. 6.11.2 Elikem Pharmaceuticals Business Overview
  64. 6.11.3 Elikem Pharmaceuticals Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Elikem Pharmaceuticals Piroxicam Capsules Product Portfolio
  66. 6.11.5 Elikem Pharmaceuticals Recent Developments
  67. 6.12 DevLife
  68. 6.12.1 DevLife Company Information
  69. 6.12.2 DevLife Business Overview
  70. 6.12.3 DevLife Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 DevLife Piroxicam Capsules Product Portfolio
  72. 6.12.5 DevLife Recent Developments
  73. 6.13 AdvaCare Pharma
  74. 6.13.1 AdvaCare Pharma Company Information
  75. 6.13.2 AdvaCare Pharma Business Overview
  76. 6.13.3 AdvaCare Pharma Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 AdvaCare Pharma Piroxicam Capsules Product Portfolio
  78. 6.13.5 AdvaCare Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Piroxicam Capsules Sales by Country
  2. 7.1.1 North America Piroxicam Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Piroxicam Capsules Sales by Country (2021-2026)
  4. 7.1.3 North America Piroxicam Capsules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Piroxicam Capsules Market Size by Country
  6. 7.2.1 North America Piroxicam Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Piroxicam Capsules Market Size by Country (2021-2026)
  8. 7.2.3 North America Piroxicam Capsules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Piroxicam Capsules Sales by Country
  2. 8.1.1 Europe Piroxicam Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Piroxicam Capsules Sales by Country (2021-2026)
  4. 8.1.3 Europe Piroxicam Capsules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Piroxicam Capsules Market Size by Country
  6. 8.2.1 Europe Piroxicam Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Piroxicam Capsules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Piroxicam Capsules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Piroxicam Capsules Sales by Country
  2. 9.1.1 Asia-Pacific Piroxicam Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Piroxicam Capsules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Piroxicam Capsules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Piroxicam Capsules Market Size by Country
  6. 9.2.1 Asia-Pacific Piroxicam Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Piroxicam Capsules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Piroxicam Capsules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Piroxicam Capsules Sales by Country
  2. 10.1.1 South America Piroxicam Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Piroxicam Capsules Sales by Country (2021-2026)
  4. 10.1.3 South America Piroxicam Capsules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Piroxicam Capsules Market Size by Country
  6. 10.2.1 South America Piroxicam Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Piroxicam Capsules Market Size by Country (2021-2026)
  8. 10.2.3 South America Piroxicam Capsules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Piroxicam Capsules Sales by Country
  2. 11.1.1 Middle East and Africa Piroxicam Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Piroxicam Capsules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Piroxicam Capsules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Piroxicam Capsules Market Size by Country
  6. 11.2.1 Middle East and Africa Piroxicam Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Piroxicam Capsules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Piroxicam Capsules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Piroxicam Capsules Value Chain Analysis
  2. 12.1.1 Piroxicam Capsules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Piroxicam Capsules Production Mode & Process
  7. 12.2 Piroxicam Capsules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Piroxicam Capsules Distributors
  10. 12.2.3 Piroxicam Capsules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst